Company Filing History:
3 out of 5,104 
3 out of 1,748 
3 out of 232 
Years Active: 2015-2022
Title: Yves Collette: Innovator in Xanthine Derivative Inhibitors
Introduction
Yves Collette is a notable inventor based in Marseilles, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of xanthine derivative compounds. With a total of 3 patents to his name, his work focuses on innovative solutions for inhibiting BET proteins.
Latest Patents
Collette's latest patents include groundbreaking inventions such as "Xanthine derivative inhibitors of BET proteins." This invention relates to xanthine derivative compounds that serve as inhibitors of BET bromodomains proteins, detailing the method of preparation and various applications. Another significant patent is "Xanthine derivatives and uses thereof as inhibitors of bromodomains of BET proteins." This invention describes a compound with a specific formula, where R is a (C-C)alkyl group, R" is preferably H, Ar is a (C-C)arylene radical, and X can be either C(=O) or SO. The compound also includes various groups such as possibly substituted (C-C)alkyl, heteroaryl, (C-C)aryl, and (hetero)cycloalkyl groups, or a pharmaceutically acceptable salt and/or tautomeric form thereof.
Career Highlights
Throughout his career, Yves Collette has worked with prestigious organizations such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Collette has collaborated with notable colleagues, including Sébastien Combes and Xavier Morelli. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Yves Collette is a distinguished inventor whose work on xanthine derivative inhibitors has the potential to impact the pharmaceutical industry significantly. His contributions, along with his collaborations, highlight the importance of innovation in addressing complex medical challenges.